Efficacy of using controlled uterine balloon tamponade for stopping atonic postpartum hemorrhage

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

BACKGROUND: Obstetric hemorrhage remains the leading cause of maternal mortality in Uzbekistan, with uterine atony in the follow-up and postpartum periods being the most common cause.

AIM: The aim of this study was to evaluate the effectiveness of using uterine balloon tamponade in atonic postpartum hemorrhage.

MATERIALS AND METHODS: This clinical controlled study was conducted at the Republican Perinatal Center of the Ministry of Health of the Republic of Uzbekistan from 2016 to 2019. Uterine balloon tamponade using a Zhukovsky balloon was used in 50 puerperas with atonic postpartum hemorrhage, of whom 40 women had vaginal delivery and ten patients were delivered by caesarean section. The control group consisted of 50 puerperas with atonic postpartum hemorrhage, traditional therapy being carried out without the use of uterine balloon tamponade, of whom 40 women had vaginal delivery and ten patients were delivered by caesarean section.

RESULTS: The total volume of blood loss in the main group was lower than in the control group: 998 ± 142 ml vs. 1498 ± 202 ml in vaginal delivery (Student’s t-test 2.01, p = 0.047563) and 1297 ± 244 ml vs. 1988 ± 226 ml at caesarean section (Student’s t-test 2.11, p = 0.039463), respectively. Uterine balloon tamponade allowed for stopping postpartum hemorrhage in the blood loss range of 750–999 ml and 1000–1499 ml in 27.5% and 52.5% of cases in the main group and in 20% and 30% of cases in the control group (OR 1.517, 95 % CI 1.536–4.293 and OR 2.579, 95% CI 1.030–6.457, respectively). When using uterine balloon tamponade, the proportion of massive bleeding with blood loss over 1500 ml was 3.8 times lower than in the control group: 10.0% (5/50) and 38% (19/50), respectively. Hysterectomy due to bleeding was performed in one (2%) postpartum woman in the main group, and in five (10%) puerperas in the control group (OR 0.184, 95% CI 1.021–6.133). The use of the tamponade test resulted in a significant decrease in the number of severe bleeding incidents (with blood loss of 1500 ml or more) by 90% during vaginal delivery (OR 0.077, 95% CI 0.009–0.635) and elevated the effectiveness of organ-preserving surgeries by 2.9 times, thus increasing the frequency of women with preserved uterus.

CONCLUSIONS: The effectiveness of uterine balloon tamponade in atonic postpartum hemorrhage was 88.0% (44/50). The simplicity and safety of using uterine balloon tamponade indicates the need for a wider introduction of this technology in postpartum hemorrhages, which will help to reduce their adverse outcomes.

全文:

受限制的访问

作者简介

Shakhida Babazhanova

Republican Perinatal Center

编辑信件的主要联系方式.
Email: shohida_bd@mail.ru

MD, Cand. Sci. (Med.), Head of obstetric department No. 1

乌兹别克斯坦, 223a, Bogishamol St., Tashkent, 100164

Adelina Lyubchich

Republican Perinatal Center

Email: shohida_bd@mail.ru

MD, Cand. Sci. (Med.)

乌兹别克斯坦, 223a, Bogishamol St., Tashkent, 100164

Natalya Lyubchich

Republican Perinatal Center

Email: shohida_bd@mail.ru

MD, Cand. Sci. (Med.), head of the obstetric department

乌兹别克斯坦, 223a, Bogishamol St., Tashkent, 100164

参考

  1. World Health Organization [Internet]. Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division: executive summary. 2019. [cited 23 Aug 2021]. Available from: https://apps.who.int/iris/handle/10665/327596
  2. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323−e333. doi: 10.1016/S2214-109X(14)70227-X
  3. Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):980−1004. doi: 10.1016/S0140-6736(14)60696-6
  4. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet. 2010;375(9726):1609−1623. doi: 10.1016/S0140-6736(10)60518-1
  5. Gupta M, Mitesh J. Role of condom catheter balloon tamponade in management of atonic postpartum haemorrhage in cases of failed medical management. Int J Clin Obstet Gynaecol. 2017;1(2):62−64.
  6. Sharma A, Bansal N, Ramola M, et al. Bakri postpartum balloon: an obstetrician’s armamentarium in managing post-partum haemorrhage. Int J Reprod Contracept Obstet Gynecol. 2020;9(5):2113−2117. doi: 10.18203/2320-1770.ijrcog20201814
  7. In the name of saving the lives of mothers. The Third Report of the Confidential Enquiries into Maternal Deaths (2016–2017). Tashkent; 2020: 112. [cited 23 Aug 2021]. Available from: https://uzbekistan.unfpa.org/sites/default/files/pub-pdf/kisms_3-y_nac_otchet_2016-2017.pdf
  8. Frenzel D, Condous GS, Papageorghiou AT, McWhinney NA. The use of the “tamponade test” to stop massive obstetric haemorrhage in placenta accrete. BJOG. 2005;112(5):676−677. doi: 10.1111/j.1471-0528.2005.00491.x
  9. Condous GS, Arulkumaran S, Symonds I, et al. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003;101(4):767−772. doi: 10.1016/s0029-7844(03)00046-2
  10. Suarez S, Conde-Agudelo A, Borovac-Pinheiro A, et al. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;222(4):293.e1−293.e52. doi: 10.1016/j.ajog.2019.11.1287

补充文件

附件文件
动作
1. JATS XML

版权所有 © Babazhanova S., Lyubchich A., Lyubchich N., 2022



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



##common.cookie##